Design of Rectenna using RF Harvesting for Batteryless IoT Sensors

In this paper, we propose a compact and highly efficient Rectenna design (rectifying antenna), operating on ISM band with the centre frequency of 2.4 GHz. A RF to DC conversion through Schottky diode (HSMS2860) is used to generate the dc voltage to operate a battery-less IoT Sensor for RF power harvesting using the designed Rectenna. We have achieved more than 80% efficiency through Advanced Design System (ADS-2016) simulation software at different power densities. Further a rectenna circuit is designed using RF to DC Schottky detector diode and a microstrip patch antenna. The rectenna circuit design is simulated through ADS 2016 simulation software. The Battery less sensor requires 2V- 2.5V dc voltage to perform an optimum performance. As per simulation and theoretical/practical modeling we have achieved more than 80% efficiency at single Schottky diode and its operating from 915 MHz to 5.8 GHz. Rectenna operates at lower power densities start from 0.4uW/cm. The proposed rectenna design is a possible candidate to be used as sensors/devices at frequency of 2.4GHz with current technologies e.g. ZigBee, Wi-Fi, BLE etc and future probable application could be long range radio sensor using the latest new generation LoRa technology its line of sight range between 10km-20km

Microfinance clients' awareness index: A measure of awareness and skills of microfinance clients

AbstractThe promotion of financial education for poor people in developing countries calls for work on several fronts, one of which is to develop a measure to evaluate the outcome of financial education in relation to broader development goals. This paper proposes a Microfinance Clients' Awareness Index (MCAI) to determine the level of financial awareness of microfinance clients. This index is a comprehensive measure that incorporates information on several aspects of financial awareness in one single number lying between 1 and 2, where 1 denotes complete ignorance and 2 indicates complete financial awareness of the microfinance product

Designing and Simulation of a Novel Multiband Antenna for Wireless Communication

ABSTRACT: An antenna is the most important element of any wireless communication. Various antennas for wide band operation have been studied & designed for communication. In this paper, a multibandmicrostrip patch with simple strip line feeding is proposed to support different wireless application. The antenna is fabricated on a FR4 substrate. To obtain multiple bands, multiple square slots are provided with the rectangular patch. The performance of the proposed antenna design is analysed with HFSS(High Frequency Structure Simulator). The relevant antenna performance parameters of the proposed design viz. resonant bands, return loss, gain, and radiation pattern are reported and discussed. The VSWR of the antenna is less than 2 for seven resonant bands in the vicinity of 1.48 GHz, 1.89 GHz, 2.06 GHz ,3.47 GHz, 4.47 GHz, 4.86 GHz and 5.31 GHz. The performance results exhibited by the proposed antenna make it extremely useful for the future generation of wireless broadband communication systems

Some results associated with a generalized basic hypergeometric function

In this paper, we define a q-extension of the new generalized hypergeometric function given by Saxena et al. in [13], and have investigated the properties of the above new function such as q-differentiation and q-integral representation. The results presented are of general character and the results given earlier by Saxena and Kalla in [14], Virchenko, Kalla and Al-Zamel in [15], Al-Musallam and Kalla in [2, 3], Kobayashi in [7, 8], Saxena et al. in [13], Kumbhat et al. in [11] follow as special cases

Buccal mucosa graft urethroplasty for anterior urethral stricture: A single-centre experience

Background :To evaluate the outcome and complications after using BMG for anterior urethral stricture. Procedure: This is a retrospective evaluation of prospectively maintained database. A total of 78 patients were operated from August 2012 to September 2019. Patients were evaluated by using IPSS score, uroflometry, post void residual urine and radiological studies. All patients were operated by using combined regional and general anaesthesia. Buccal mucosa was used in all except three where lingual mucosa was also harvested. The catheter was removed at 3-4 weeks after surgery and patients were followed up at one, three and six months, and then three monthly thereafter.The procedure was considered successful if no intervention was required after surgery. Conclusion: In 78 patient’s total of 89 procedures have been done over seven years. The procedure was successful in 84.93%, and it failed in 11 patients over a mean follow up of 45 months (7-59 months). In three patients, single DVIU was sufficient whereas in four regular CIC was required after DVIU. In four patients redo surgery was done after six months. Two patients required staged procedure and in three permanent perineal urethrostomy were made due to poor urethral condition, all in older patients. These five patients were excluded from the study. Anastomotic narrowing was most common finding. Redo urethroplasty was successful in all patients.Buccal mucosa as a free graft provides excellent functional outcome in anterior urethral stricture

Epidemiology of cardioprotective pharmacological agent use in stable coronary heart disease

AbstractObjectiveTo determine use of class and type of cardioprotective pharmacological agents in patients with stable coronary heart disease (CHD) we performed a prescription audit.MethodsA cross sectional survey was conducted in major districts of Rajasthan in years 2008–09. We evaluated prescription for classes (anti-platelets, β-blockers, angiotensin converting enzyme (ACE) inhibitors, angiotensin receptor blockers (ARB), calcium channel blockers (CCB) and statins) and specific pharmacological agents at clinics of physicians in tertiary (n = 18), secondary (n = 69) and primary care (n = 43). Descriptive statistics are reported.ResultsPrescriptions of 2290 stable CHD patients were audited. Anti-platelet use was in 2031 (88.7%), β-blockers 1494 (65.2%), ACE inhibitors 1196 (52.2%), ARBs 712 (31.1%), ACE inhibitors – ARB combinations 19 (0.8%), either ACE inhibitors or ARBs 1908 (83.3%), CCBs 1023 (44.7%), statins 1457 (63.6%) and other lipid lowering agents in 170 (7.4%). Among anti-platelets aspirin–clopidogrel combination was used in 88.5%. Top three molecules in β-blockers were atenolol (37.8%), metoprolol (26.4%) and carvedilol (11.9%); ACE inhibitors ramipril (42.1%), lisinopril (20.3%) and perindopril (10.9%); ARB's losartan (47.7%), valsartan (22.3%) and telmisartan (14.9%); CCBs amlodipine (46.7%), diltiazem (29.1%) and verapamil (9.5%) and statins were atorvastatin (49.8%), simvastatin (28.9%) and rosuvastatin (18.3%). Use of metoprolol, ramipril, valsartan, diltiazem and atorvastatin was more at tertiary care, and atenolol, lisinopril, losartan, amlodipine and simvasatin in primary care (p < 0.01).ConclusionsThere is low use of β-blockers, ACE inhibitors, ARBs and statins in stable CHD patients among physicians in Rajasthan. Significant differences in use of specific molecules at primary, secondary and tertiary healthcare are observed

Divergent trends in ischaemic heart disease and stroke mortality in India from 2000 to 2015: a nationally representative mortality study.

INTRODUCTION: India accounts for about a fifth of cardiovascular deaths globally, but nationally representative data on mortality trends are not yet available. In this nationwide mortality study, we aimed to assess the trends in ischaemic heart disease and stroke mortality over 15 years using the Million Death Study. METHODS: We determined national and subnational cardiovascular mortality rates and trends by sex and birth cohort using cause of death ascertained by verbal autopsy from 2001 to 2013 among 2·4 million households. We derived mortality rates for ischaemic heart disease and stroke by applying mortality proportions to UN mortality estimates for India and projected the rates from 2000 to 2015. FINDINGS: Cardiovascular disease caused more than 2·1 million deaths in India in 2015 at all ages, or more than a quarter of all deaths. At ages 30-69 years, of 1·3 million cardiovascular deaths, 0·9 million (68·4%) were caused by ischaemic heart disease and 0·4 million (28·0%) by stroke. At these ages, the probability of dying from ischaemic heart disease increased during 2000-15, from 10·4% to 13·1% in men and 4·8% to 6·6% in women. Ischaemic heart disease mortality rates in rural areas increased rapidly and surpassed those in urban areas. By contrast, the probability of dying from stroke decreased from 5·7% to 5·0% in men and 5·0% to 3·9% in women. A third of premature stroke deaths occurred in the northeastern states, inhabited by a sixth of India's population, where rates increased significantly and were three times higher than the national average. The increased mortality rates of ischaemic heart disease nationally and stroke in the northeastern states were higher in the cohorts of adults born in the 1970s onwards, than in earlier decades. A large and growing proportion of the ischaemic heart disease nationally and stroke deaths in high-burden states reported earlier diagnosis of cardiovascular disease, but low medication use. INTERPRETATION: The unexpectedly diverse patterns of cardiovascular mortality require investigation to identify the role of established and new cardiovascular risk factors. Secondary prevention with effective and inexpensive long-term treatment and adult smoking cessation could prevent substantial numbers of premature deaths. Without progress against the control of cardiovascular disease in India, global goals to reduce non-communicable diseases by 2030 will be difficult to achieve. FUNDING: Fogarty International Center of the US National Institutes of Health, Dalla Lana School of Public Health, University of Toronto, Indian Council of Medical Research, and the Disease Control Priorities

Assessing recreational fisheries in an emerging economy: Knowledge,perceptions and attitudes of catch-and-release anglers in India

ABSTRACT: Across the globe, catch-and-release (C&R) angling represents a leisure activity indulged by millions. The practice of C&R is commonly advocated by conservation managers because of its potential to protect local fish populations from a range of anthropogenic threats, including over-fishing. In India, C&R angling in fresh waters has a history dating back to colonial times. Despite this, little is known about the current state of the sector. To address this, an online web-based survey was conducted to target C&R anglers who fish in Indian rivers to assess their knowledge, attitudes and perceptions relating to the status of India's freshwater C&R fisheries. From a total of 148 responses, factors such as angling quality (score of 4.6/5.0); aesthetics of surroundings (4.6/5.0), presence of other wildlife (4.4/5.0), fishery management practices (4.6/5.0) and socioeconomic benefits (4.4/5.0) were evaluated. Over 65% (n = 148) of the anglers reported an observed decrease in the quality of fishing (e.g. a reduction in the size and/or numbers of fish available for capture). Respondents also considered deforestation (score of 4.2/5.0), water abstraction (4.4/5.0), pollution (4.4/5.0), hydropower projects (4.2/5.0) and destructive fishing techniques (4.7/5.0) as factors which threaten both the habitat and species they target. C&R practitioners were largely united regarding the benefits and willingness to contribute both their time and financial input to support conservation initiatives (score of 4.7/5.0). The current study provides the first overview of the status of C&R angling in India and explores challenges, opportunities, and priorities for future resource management

Spatial, temporal, and demographic patterns in prevalence of chewing tobacco use in 204 countries and territories, 1990-2019 : a systematic analysis from the Global Burden of Disease Study 2019

Interpretation Chewing tobacco remains a substantial public health problem in several regions of the world, and predominantly in south Asia. We found little change in the prevalence of chewing tobacco use between 1990 and 2019, and that control efforts have had much larger effects on the prevalence of smoking tobacco use than on chewing tobacco use in some countries. Mitigating the health effects of chewing tobacco requires stronger regulations and policies that specifically target use of chewing tobacco, especially in countries with high prevalence. Findings In 2019, 273 center dot 9 million (95% uncertainty interval 258 center dot 5 to 290 center dot 9) people aged 15 years and older used chewing tobacco, and the global age-standardised prevalence of chewing tobacco use was 4 center dot 72% (4 center dot 46 to 5 center dot 01). 228 center dot 2 million (213 center dot 6 to 244 center dot 7; 83 center dot 29% [82 center dot 15 to 84 center dot 42]) chewing tobacco users lived in the south Asia region. Prevalence among young people aged 15-19 years was over 10% in seven locations in 2019. Although global agestandardised prevalence of smoking tobacco use decreased significantly between 1990 and 2019 (annualised rate of change: -1 center dot 21% [-1 center dot 26 to -1 center dot 16]), similar progress was not observed for chewing tobacco (0 center dot 46% [0 center dot 13 to 0 center dot 79]). Among the 12 highest prevalence countries (Bangladesh, Bhutan, Cambodia, India, Madagascar, Marshall Islands, Myanmar, Nepal, Pakistan, Palau, Sri Lanka, and Yemen), only Yemen had a significant decrease in the prevalence of chewing tobacco use, which was among males between 1990 and 2019 (-0 center dot 94% [-1 center dot 72 to -0 center dot 14]), compared with nine of 12 countries that had significant decreases in the prevalence of smoking tobacco. Among females, none of these 12 countries had significant decreases in prevalence of chewing tobacco use, whereas seven of 12 countries had a significant decrease in the prevalence of tobacco smoking use for the period. Summary Background Chewing tobacco and other types of smokeless tobacco use have had less attention from the global health community than smoked tobacco use. However, the practice is popular in many parts of the world and has been linked to several adverse health outcomes. Understanding trends in prevalence with age, over time, and by location and sex is important for policy setting and in relation to monitoring and assessing commitment to the WHO Framework Convention on Tobacco Control. Methods We estimated prevalence of chewing tobacco use as part of the Global Burden of Diseases, Injuries, and Risk Factors Study 2019 using a modelling strategy that used information on multiple types of smokeless tobacco products. We generated a time series of prevalence of chewing tobacco use among individuals aged 15 years and older from 1990 to 2019 in 204 countries and territories, including age-sex specific estimates. We also compared these trends to those of smoked tobacco over the same time period. Findings In 2019, 273 & middot;9 million (95% uncertainty interval 258 & middot;5 to 290 & middot;9) people aged 15 years and older used chewing tobacco, and the global age-standardised prevalence of chewing tobacco use was 4 & middot;72% (4 & middot;46 to 5 & middot;01). 228 & middot;2 million (213 & middot;6 to 244 & middot;7; 83 & middot;29% [82 & middot;15 to 84 & middot;42]) chewing tobacco users lived in the south Asia region. Prevalence among young people aged 15-19 years was over 10% in seven locations in 2019. Although global age standardised prevalence of smoking tobacco use decreased significantly between 1990 and 2019 (annualised rate of change: -1 & middot;21% [-1 & middot;26 to -1 & middot;16]), similar progress was not observed for chewing tobacco (0 & middot;46% [0 & middot;13 to 0 & middot;79]). Among the 12 highest prevalence countries (Bangladesh, Bhutan, Cambodia, India, Madagascar, Marshall Islands, Myanmar, Nepal, Pakistan, Palau, Sri Lanka, and Yemen), only Yemen had a significant decrease in the prevalence of chewing tobacco use, which was among males between 1990 and 2019 (-0 & middot;94% [-1 & middot;72 to -0 & middot;14]), compared with nine of 12 countries that had significant decreases in the prevalence of smoking tobacco. Among females, none of these 12 countries had significant decreases in prevalence of chewing tobacco use, whereas seven of 12 countries had a significant decrease in the prevalence of tobacco smoking use for the period. Interpretation Chewing tobacco remains a substantial public health problem in several regions of the world, and predominantly in south Asia. We found little change in the prevalence of chewing tobacco use between 1990 and 2019, and that control efforts have had much larger effects on the prevalence of smoking tobacco use than on chewing tobacco use in some countries. Mitigating the health effects of chewing tobacco requires stronger regulations and policies that specifically target use of chewing tobacco, especially in countries with high prevalence. Copyright (c) 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.Peer reviewe